Isoniazid preventive therapy for HIV-infected people: evidence to support implementation
- PMID: 21079422
- DOI: 10.1097/01.aids.0000391009.95149.ec
Isoniazid preventive therapy for HIV-infected people: evidence to support implementation
Similar articles
-
Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study.AIDS. 2010 Nov;24 Suppl 5:S45-8. doi: 10.1097/01.aids.0000391021.18284.12. AIDS. 2010. PMID: 21079427
-
The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting.Thorax. 2011 Jun;66(6):496-501. doi: 10.1136/thx.2010.156752. Epub 2011 Apr 2. Thorax. 2011. PMID: 21460373 Clinical Trial.
-
Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans.N Engl J Med. 1998 Mar 19;338(12):841; author reply 842-3. doi: 10.1056/NEJM199803193381214. N Engl J Med. 1998. PMID: 9508639 No abstract available.
-
Tuberculosis preventive therapy for HIV-infected persons in less developed countries.Int J Tuberc Lung Dis. 2000 Feb;4(2 Suppl 1):S76-81. Int J Tuberc Lung Dis. 2000. PMID: 10688154 Review. No abstract available.
-
Diagnosis and management of tuberculosis in patients with HIV infection.Mt Sinai J Med. 1998 Jan;65(1):14-21. Mt Sinai J Med. 1998. PMID: 9458679 Review. No abstract available.
Cited by
-
Provider barriers to the uptake of isoniazid preventive therapy among people living with HIV in Ethiopia.Int J Tuberc Lung Dis. 2019 Mar 1;23(3):371-377. doi: 10.5588/ijtld.18.0378. Int J Tuberc Lung Dis. 2019. PMID: 30871669 Free PMC article.
-
Improving the prevention, diagnosis and treatment of TB among people living with HIV: the role of operational research.J Int AIDS Soc. 2011 Jul 6;14 Suppl 1(Suppl 1):S5. doi: 10.1186/1758-2652-14-S1-S5. J Int AIDS Soc. 2011. PMID: 21967874 Free PMC article. Review.
-
Perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings: a qualitative study.Pan Afr Med J. 2014 Jan 17;17:26. doi: 10.11604/pamj.2014.17.26.2641. eCollection 2014. Pan Afr Med J. 2014. PMID: 24932337 Free PMC article.
-
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.N Engl J Med. 2019 Mar 14;380(11):1001-1011. doi: 10.1056/NEJMoa1806808. N Engl J Med. 2019. PMID: 30865794 Free PMC article. Clinical Trial.
-
Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based Dosing.Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0238521. doi: 10.1128/aac.02385-21. Epub 2022 Aug 9. Antimicrob Agents Chemother. 2022. PMID: 35943252 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical